A randomized trial of Lactobacillus plantarum CJLP133 for the treatment of atopic dermatitis
- 11 October 2012
- journal article
- research article
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 23 (7), 667-673
- https://doi.org/10.1111/pai.12010
Abstract
There have been considerable disagreements regarding the therapeutic effects of probiotics in atopic dermatitis (AD). We performed this study to examine whether the oral administration of Lactobacillus plantarum CJLP133 improves pediatric AD. In a randomized, double-blind, placebo-controlled study, either L. plantarum CJLP133 at a dosage of 0.5 × 10(10) colony-forming units or placebo in children aged 12 months to 13 yr was given twice a day for 12 wk. SCOring of Atopic Dermatitis (SCORAD) scores, eosinophil counts, serum total IgE, and cytokines were evaluated. Forty-four of 58 patients in the probiotic group and 39 of 60 patients in the placebo group completed the study. The SCORAD score at week 14 was lower in the probiotic group than in the placebo group (p = 0.044). The mean change in the SCORAD score from weeks 2 to 14 was 9.1 in the probiotic group, which was greater than the mean change of 1.8 in the placebo group (p = 0.004). No statistical differences in the total use of topical corticosteroids were found between two groups (p = 0.815). In the probiotic group, the total eosinophil count was significantly lower at the end of the intervention compared to the baseline measurements (p = 0.023). Logarithmic IFN-γ and IL-4 were significantly decreased by the end of the intervention compared to baseline measurements in the probiotic group (p < 0.001 and 0.049). Our results suggest that supplementation with probiotic L. plantarum CJLP133 is beneficial in the treatment of pediatric AD.Keywords
This publication has 30 references indexed in Scilit:
- Advances in atopic dermatitisCurrent Opinion in Immunology, 2011
- Evaluation of probiotic characteristics of newly isolated Lactobacillus spp.: Immune modulation and longevityInternational Journal of Food Microbiology, 2011
- Oral administration of Lactobacillus strains from Kimchi inhibits atopic dermatitis in NC / Nga miceJournal of Applied Microbiology, 2011
- Review Article: Probiotics for allergic diseases: Realities and mythsPediatric Allergy and Immunology, 2010
- Effect of Lactobacillus sakei supplementation in children with atopic eczema–dermatitis syndromeAnnals of Allergy, Asthma & Immunology, 2010
- Generation of regulatory dendritic cells and CD4 + Foxp3 + T cells by probiotics administration suppresses immune disordersProceedings of the National Academy of Sciences of the United States of America, 2010
- Randomized, placebo‐controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancyAllergy, 2007
- No effects of probiotics on atopic dermatitis in infancy: a randomized placebo‐controlled trialClinical and Experimental Allergy, 2006
- Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathwayJournal of Allergy and Clinical Immunology, 2006
- T cell–mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitisJCI Insight, 2000